*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : HO0875000
CHEMICAL NAME : 5H-Dibenz(b,f)azepine,
10,11-dihydro-5-(3-(4-piperidino-4-carbamoylpiperidin
o)propyl)-
CAS REGISTRY NUMBER : 5942-95-0
BEILSTEIN REFERENCE NO. : 0502521
REFERENCE : 5-22-13-00540 (Beilstein Handbook Reference)
LAST UPDATED : 199612
DATA ITEMS CITED : 7
MOLECULAR FORMULA : C28-H38-N4-O
MOLECULAR WEIGHT : 446.70
WISWESSER LINE NOTATION : T C676 BN&T&J B3- AT6NTJ DVZ D- AT6NTJ
SYNONYMS/TRADE NAMES :
* Carbadipimidine
* Carpipramine
* PZ-1511
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1025 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,63,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 76 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,63,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 37 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,63,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2180 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,63,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 136 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,38,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 28 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,63,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 18 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,63,1972
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-morpholinopropionyl)-
| 18300-60-2 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-morpholinopropyl)-
| 18300-60-2 |
3,8-Diazabicyclo(3.2.1)octane,3-methyl-8-((2'-nitrothien-5'-yl)vinyl)carbonyl-
| 57269-49-5 |
3,7a-Diazacyclohepta(jk)fluoren-7(1H)-one,2,3,3a,4,5,6-hexahydro-10-chloro-3-(phenylmethyl)-,(+-)-, monomethanesulfonate
| 87255-61-6 |
5H-Dibenz(b,e)azepine,6,11-dihydro-5-(4-morpholinylacetyl)-,monohydrochloride
| 70337-07-4 |
5H-Dibenz(c,e)azepine, 6,7-dihydro-6-phenethyl-
| 53873-58-8 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-(4-piperidino-4-carbamoylpiperidino)propyl)-
| 5942-95-0 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(2-piperidinoethyl)-,monohydrochloride
| 5942-95-0 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(m-(piperidinomethyl)benzoyl)-,hydrochloride
| 5942-95-0 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(o-(piperidinomethyl)benzoyl)-,hydrochloride
| 5942-95-0 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(p-(piperidinomethyl)benzoyl)-,hydrochloride
| 5942-95-0 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-(4-piperidinopiperidino)propyl)-,dihydrochloride
| 28028-19-5 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-piperidinopropionyl)-
| 26082-81-5 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-piperidinopropyl)-
| 26082-81-5 |
3,7a-Diazacyclohepta(jk)fluoren-7(1H)-one,2,3,3a,4,5,6-hexahydro-5,5-dimethyl-3-(phenylmethyl)-, (+-)-, (Z)-2-butenedioate (1:1)
| 87255-56-9 |
5H-Dibenz(b,e)azepine,6,11-dihydro-5-(1-piperidinylacetyl)-,monohydrochloride
| 70337-06-3 |
5H-Dibenz(b,f)azepine,10,11-dihydro-2-(1-piperidinylmethyl)-
| 64097-56-9 |
5H-Dibenz(c,e)azepine, 6,7-dihydro-6-(2-propenyl)-,hydrochloride
| 65-15-6 |
5H-Dibenz(c,e)azepine, 6,7-dihydro-6-propyl-
| 58335-95-8 |
5H-Dibenz(c,e)azepine, 6,7-dihydro-6-(2-propynyl)-,hydrochloride
| 51839-51-1 |
5H-Dibenz(b,e)azepine,6,11-dihydro-5-(1-pyrrolidinylacetyl)-,monohydrochloride
| 70337-09-6 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(2-(1-pyrrolidinyl)ethyl)-,monohydrochloride
| 70337-09-6 |
5H-Dibenz(b,f)azepine,10,11-dihydro-2-(1-pyrrolidinylmethyl)-
| 64097-59-2 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(m-(1-pyrrolidinylmethyl)benzoyl)-,hydrochloride
| 64097-59-2 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(o-(1-pyrrolidinylmethyl)benzoyl)-,hydrochloride
| 64097-59-2 |
3,7a-Diazacyclohepta(jk)fluoren-7(1H)-one,2,3,3a,4,5,6-hexahydro-6,6-dimethyl-3-(phenylmethyl)-, (+-)-, (Z)-2-butenedioate (1:1)
| 87255-69-4 |
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(p-(1-pyrrolidinylmethyl)benzoyl)-,hydrochloride
| 87255-69-4 |
5H-Dibenz(b,f)azepine, 10-(2-(dimethylamino)ethyl)-
| 41972-85-4 |
5H-Dibenz(b,f)azepine,10-(2-(dimethylamino)ethyl)-5-ethyl-
| 84142-15-4 |
5H-Dibenz(b,f)azepine,10-(2-(dimethylamino)ethyl)-8-(ethylsulfonyl)-5-methyl-, hydrochloride
| 52813-92-0 |
5H-Dibenz(b,f)azepine,10-(2-(dimethylamino)ethyl)-8-(ethylthio)-5-methyl-,hydrochloride
| 52813-90-8 |
5H-Dibenz(b,f)azepine,10-(2-(dimethylamino)ethyl)-5-methyl-
| 30490-51-8 |
5H-Dibenz(b,f)azepine, 10-(2-(dimethylamino)ethyl)-,oxalate
| 101607-50-5 |
5H-Dibenz(b,f)azepine,5-(2'-(N,N-dimethylamino)-2'-methyl)ethyl-
| 63918-76-3 |
5H-Dibenz(b,f)azepine,10-(dimethylaminomethyl)-5-methyl-, hydrochloride
| 28941-77-7 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-
| 739-71-9 |
3,7a-Diazacyclohepta(jk)fluoren-7(1H)-one,2,3,3a,4,5,6-hexahydro-6,6-dimethyl-, (+-)-,(Z)-2-butenedioate (1:1)
| 87255-66-1 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-,(-)-
| 3564-75-8 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-,(+)-
| 3564-66-7 |
5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-
| 303-54-8 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-
| 50-49-7 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-, and3H-1,4- benzodiazepine,7-chloro-2-(methylamino)-5-phenyl-, 4-oxide (2:1)
| 63918-77-4 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-, and2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)pyridine (1:1)
| 63918-77-4 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro- mixed withethyl alcoholSUBSTANCE DEFINITION :94% 5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-:6%ethyl alcoholREFERENCE :AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (HeymansInstitute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-1898- Volume(issue)/page/year: 148,560,1964
| 63918-77-4 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-,monohydrochloride
| 113-52-0 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-, 5-oxide
| 2207-85-4 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-, 5-oxide,monohydrochloride
| 19864-71-2 |
3,7a-Diazacyclohepta(jk)fluoren-7(1H)-one,2,3,3a,4,5,6-hexahydro-5,5-dimethyl-, (+-)-,(Z)-2-butenedioate (1:1)
| 87255-59-2 |
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-, mixedwith sodium nitrite (1:4)
| 87255-59-2 |
5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-,fumarate
| 72629-48-2 |
|
|